COVID-19 Update - This is to inform you that the Government of India has announced a complete lockdown in India 22nd March 2020 to 14th April 2020. As a result, our offices will now be closed till 14th April 2020 and all our employees will be working from home. Office telephones will not be answered, and therefore you are requested to direct all your queries related to manuscript submission, review process, publication etc. at below mentioned details.,, Mob. 8826373757, 8826859373, 9910947804

Article view: 465

Article download: 191

Panacea Journal of Medical Sciences

Correlation of serum uric acid levels in patients of chronic obstructive pulmonary disease

Full Text PDF Share on Facebook Share on Twitter

Author Details : Anil Sontakke, Shashank Kharwade, B. O. Tayade

Volume : 8, Issue : 1, Year : 2018

Article Page : 16-20

Suggest article by email


To evaluate serum uric acid level and correlate with the classification of chronic obstructive pulmonary disease (COPD) severity based on post-bronchodilator FEV1 as per Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines. It is an institution based cross-sectional study in which 100 patients were included. Patients were screened for COPD. Clinical profile and oxygen saturation were included. Patients were classified according to GOLD guidelines. We found that serum uric acid level was at higher side in patients of severe and very severe stages of COPD compared to mild and moderate stages. Inverse relationship found between FEV1 and serum uric acid level. We concluded that uric acid is a widely available, easy to interpret, low cost biomarker, suggests the possible role in the identification of COPD patients of increased risk for adverse outcomes that may need early intensive management.

Keywords: Chronic obstructive pulmonary disease, GOLD guidelines, Spirometry, Serum uric acid.

Doi : 10.18231/2348-7682.2018.0004

How to cite : Sontakke A, Kharwade S, Tayade B O, Correlation of serum uric acid levels in patients of chronic obstructive pulmonary disease. Panacea J Med Sci 2018;8(1):16-20

Copyright © 2018 by author(s) and Panacea J Med Sci. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0) (